Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy Study of Antihistamine V0114 CP 2.5 mg Tablet in Allergic Rhinitis
2006-006947-30Phase 3Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levocetirizine in allergic rhinitis (AR), sponsored by Pierre Fabre Laboratories. Primary endpoint: Efficacy. Started Mar 2007; status: completed.
02
Drugs
levocetirizine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on 2006-006947-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006947-30.